48,466
edits
Difference between revisions of "Biphenotypic sinonasal sarcoma"
Jump to navigation
Jump to search
→IHC
(→IHC) |
|||
| Line 31: | Line 31: | ||
*S-100 +ve - strong (28 +ve of 28 cases<ref name=pmid22301502/>). | *S-100 +ve - strong (28 +ve of 28 cases<ref name=pmid22301502/>). | ||
*Actin +ve (27 +ve of 28 cases<ref name=pmid22301502/>). | *Actin +ve (27 +ve of 28 cases<ref name=pmid22301502/>). | ||
*Beta-catenin - nuclear +ve.<ref>http://dx.doi.org/10.1016/j.humpath.2016.04.009 | |||
</ref><reF>{{Cite journal | last1 = Powers | first1 = KA. | last2 = Han | first2 = LM. | last3 = Chiu | first3 = AG. | last4 = Aly | first4 = FZ. | title = Low-grade sinonasal sarcoma with neural and myogenic features--diagnostic challenge and pathogenic insight. | journal = Oral Surg Oral Med Oral Pathol Oral Radiol | volume = 119 | issue = 5 | pages = e265-9 | month = May | year = 2015 | doi = 10.1016/j.oooo.2014.10.007 | PMID = 25488011 }}</ref> | |||
==Molecular== | ==Molecular== | ||